| Literature DB >> 24501288 |
.
Abstract
With new safety measures in place, the U.S. Food and Drug Administration will allow Ariad Pharmaceuticals to resume marketing Iclusig, sales of which were suspended in October 2013.Mesh：
Substances：
Year: 2014 PMID： 24501288 DOI： 10.1158/2159-8290.CD-NB2014-001
Source DB: PubMed Journal: Cancer Discov ISSN： 2159-8274 Impact factor: 39.397